Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $148.0300 (0.45%) ($147.1400 - $149.3900) on Fri. May. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.47% (three month average) | RSI | 32 | Latest Price | $148.0300(0.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(16%) XBI(15%) XOP(15%) XLE(12%) IWC(11%) | Factors Impacting ABBV price | ABBV will decline at least -0.735% in a week (0% probabilities). XLC(-23%) BWX(-13%) VUG(-12%) XLK(-11%) QQQ(-11%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.735% (StdDev 1.47%) | Hourly BBV | 0.1 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $157.51 | 5 Day Moving Average | $149.99(-1.31%) | 10 Day Moving Average | $153.72(-3.7%) | 20 Day Moving Average | $157.51(-6.02%) | To recent high | -10.2% | To recent low | 2.4% | Market Cap | $261.167b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |